Publications

Osteoporosis

• 2024 ASBMR Poster
• 2024 JBMR Editorial
• 2024 Entera Phase 2 Osteoporosis Paper in JBMR
• 2023 ASBMR Poster 1
• 2023 ASBMR Poster 2
• 2022 ASBMR Poster
• 2021 ASBMR Presentation - 6 Month BMD

• 2021 ASBMR Poster - Bone Markers
• 2018 ASBMR Poster
• 2017 ASBMR Poster
• 2016 ASBMR Poster
• 2014 ASBMR Poster (Entera +UEA)
• 2013 ASBMR Poster

Hypoparathyroidism

• 2024 ENDO Poster
• 2021 June, Entera Hypo Paper in JBMR
• 2019 ASBMR Poster
• 2015 ASBMR Poster PH2a HypoPT

Platform
Technology

• The Combined Effect of Permeation Enhancement and Proteolysis Inhibition on the Systemic Exposure of Orally Administrated Peptides

Other Targets

• Oral Delivery Technology Enabling Gastro-Mucosal Absorption of Glucagon-Like-Peptide-2 Analog (Teduglutide) - A Novel Approach for Injection-Free Treatment of Short Bowel Syndrome